Mankind Pharma Ltd. - Research Center
543904 MANKIND Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 2,152.69 | 2,358.57 | 2,453.35 | 2,300.21 | 1,872.12 |
| Operating profit | 547.33 | 603.11 | 635.19 | 539.47 | 381.16 |
| Interest | 4.03 | 4.26 | 4.31 | 1.97 | 0.88 |
| Gross profit | 627.15 | 666.08 | 689.00 | 594.94 | 422.73 |
| EPS (Rs) | 11.34 | 12.16 | 11.80 | 10.22 | 7.01 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 83.85 | 67.23 | 58.12 | 57.44 | 42.46 |
| Stock adjustment | -67.33 | 24.14 | -2.08 | 19.91 | 21.00 |
| Raw material | 213.15 | 205.21 | 229.96 | 213.41 | 163.93 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 507.93 | 492.68 | 500.29 | 481.20 | 431.07 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 951.60 | 1,033.43 | 1,089.98 | 1,046.22 | 874.96 |
| Provisions made | - | - | - | - | - |
| Depreciation | 82.29 | 89.73 | 77.04 | 68.54 | 67.30 |
| Taxation | 90.69 | 89.28 | 139.08 | 117.11 | 74.45 |
| Net profit / loss | 454.17 | 487.07 | 472.88 | 409.28 | 280.99 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 40.06 | 40.06 | 40.06 | 40.06 | 40.06 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 25.43 | 25.57 | 25.89 | 23.45 | 20.36 |
| GPM (%) | 28.04 | 27.46 | 27.43 | 25.23 | 22.08 |
| NPM (%) | 20.31 | 20.08 | 18.83 | 17.36 | 14.68 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis